Anti-SIV VPX Polyclonal Antibody from ProteoGenix; catalogue ARO-A22440; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anti-SIV VPX Polyclonal Antibody: A Powerful Tool for SIV Research
The Anti-SIV VPX Polyclonal Antibody is a highly specific and reliable research tool for the study of Simian Immunodeficiency Virus (SIV). Developed by our team of experts in biotechnology, this antibody is designed to target the VPX protein of SIV, making it an essential tool for researchers studying this virus.
The VPX protein is an important component of SIV, playing a crucial role in the replication and pathogenesis of the virus. The Anti-SIV VPX Polyclonal Antibody binds to this protein, inhibiting its function and preventing the virus from replicating. This makes it an invaluable tool for understanding the mechanisms of SIV infection and developing potential treatments.
The Anti-SIV VPX Polyclonal Antibody has a wide range of applications in SIV research. It can be used for the detection and quantification of SIV in infected samples, as well as for the study of SIV-host interactions. Additionally, this antibody can be used in immunofluorescence and immunohistochemistry experiments to visualize the distribution and localization of SIV VPX in cells and tissues.
One of the key advantages of the Anti-SIV VPX Polyclonal Antibody is its versatility in various experimental settings. For example, it has been used in Western blotting to detect the expression of SIV VPX in cell lysates. It has also been used in co-immunoprecipitation experiments to identify protein interactions with SIV VPX. Furthermore, this antibody has been successfully used in in vitro and in vivo studies to investigate the role of SIV VPX in viral pathogenesis.
Conclusion:
In summary, the Anti-SIV VPX Polyclonal Antibody is an essential tool for researchers studying SIV. With its high specificity and reliability, it allows for accurate and detailed analysis of SIV VPX and its functions. Whether you are studying the basic biology of SIV or developing potential treatments for SIV infection, this antibody is a valuable addition to your research arsenal. Order now and take your SIV research to the next level.
ProteoGenix catalogue number ARO-A22440. For research use only.
Target: vpx protein, vpx; Clonality: Polyclonal Antibody; Applications: ELISA, IHC.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| vpx protein, vpx |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
